Similar articles

• Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.

  Collen D, Van de Werf F. Collen D, et al. Am J Cardiol. 1987 Sep 1;60(7):431-4. doi: 10.1016/0002-9149(87)90280-3. Am J Cardiol. 1987. PMID: 3115077
• [Coronary thrombolysis in patients with acute myocardial infarction].

  Kambara H, Fudo T, Ono S. Kambara H, et al. Kokyu To Junkan. 1992 Jun;40(6):537-47. Kokyu To Junkan. 1992. PMID: 1620990 Review. Japanese. No abstract available.
• [New thrombolytic agents in myocardial infarction].

  Charbonnier B, Lang M, Brochier M. Charbonnier B, et al. Arch Mal Coeur Vaiss. 1987 Nov;80(12):1785-91. Arch Mal Coeur Vaiss. 1987. PMID: 3128222 Review. French.
• Thrombolytic treatment in acute myocardial infarction.

  Acar J, Vahanian A, Michel PL, Slama M, Cormier B, Roger V. Acar J, et al. Semin Thromb Hemost. 1987 Apr;13(2):186-200. doi: 10.1055/s-2007-1003492. Semin Thromb Hemost. 1987. PMID: 2957791 Review. No abstract available.
• Coronary thrombolysis with clot-selective plasminogen activators.

  Collen D, Bounameaux H. Collen D, et al. Herz. 1986 Feb;11(1):9-15. Herz. 1986. PMID: 3082731